\\n\\n
Released this past November, the list is based on data collected from the Web of Science and highlights some of the world’s most influential scientific minds by naming the researchers whose publications over the previous decade have included a high number of Highly Cited Papers placing them among the top 1% most-cited.
\\n\\nWe wish to congratulate all of the researchers named and especially our authors on this amazing accomplishment! We are happy and proud to share in their success!
\\n"}]',published:!0,mainMedia:null},components:[{type:"htmlEditorComponent",content:'IntechOpen is proud to announce that 179 of our authors have made the Clarivate™ Highly Cited Researchers List for 2020, ranking them among the top 1% most-cited.
\n\nThroughout the years, the list has named a total of 252 IntechOpen authors as Highly Cited. Of those researchers, 69 have been featured on the list multiple times.
\n\n\n\nReleased this past November, the list is based on data collected from the Web of Science and highlights some of the world’s most influential scientific minds by naming the researchers whose publications over the previous decade have included a high number of Highly Cited Papers placing them among the top 1% most-cited.
\n\nWe wish to congratulate all of the researchers named and especially our authors on this amazing accomplishment! We are happy and proud to share in their success!
\n'}],latestNews:[{slug:"intechopen-authors-included-in-the-highly-cited-researchers-list-for-2020-20210121",title:"IntechOpen Authors Included in the Highly Cited Researchers List for 2020"},{slug:"intechopen-maintains-position-as-the-world-s-largest-oa-book-publisher-20201218",title:"IntechOpen Maintains Position as the World’s Largest OA Book Publisher"},{slug:"all-intechopen-books-available-on-perlego-20201215",title:"All IntechOpen Books Available on Perlego"},{slug:"oiv-awards-recognizes-intechopen-s-editors-20201127",title:"OIV Awards Recognizes IntechOpen's Editors"},{slug:"intechopen-joins-crossref-s-initiative-for-open-abstracts-i4oa-to-boost-the-discovery-of-research-20201005",title:"IntechOpen joins Crossref's Initiative for Open Abstracts (I4OA) to Boost the Discovery of Research"},{slug:"intechopen-hits-milestone-5-000-open-access-books-published-20200908",title:"IntechOpen hits milestone: 5,000 Open Access books published!"},{slug:"intechopen-books-hosted-on-the-mathworks-book-program-20200819",title:"IntechOpen Books Hosted on the MathWorks Book Program"},{slug:"intechopen-s-chapter-awarded-the-guenther-von-pannewitz-preis-2020-20200715",title:"IntechOpen's Chapter Awarded the Günther-von-Pannewitz-Preis 2020"}]},book:{item:{type:"book",id:"5286",leadTitle:null,fullTitle:"Products from Olive Tree",title:"Products from Olive Tree",subtitle:null,reviewType:"peer-reviewed",abstract:"Olive tree products provide a number of documented presentations of the production and quality of the two most important olive tree products: virgin olive oil and table olives. It is a source that familiarizes readers with recent approaches and innovations that can be introduced in the virgin olive oil extraction and stabilization technology and the preparation of table olives with emphasis on the presence of bioactive constituents. It also describes advances in the methods of checking authenticity and in the evaluation of attributes that may influence consumers' perceptions and preferences. Other topics discussed are squalene, a trove of metabolic actions, pigments, geographical indication, biotechnology in table olive preparation, and recovery of hydroxytyrosol from olive-milling wastes.",isbn:"978-953-51-2725-3",printIsbn:"978-953-51-2724-6",pdfIsbn:"978-953-51-4164-8",doi:"10.5772/61902",price:139,priceEur:155,priceUsd:179,slug:"products-from-olive-tree",numberOfPages:344,isOpenForSubmission:!1,isInWos:1,hash:"b1c4ed3e0237d388a235b51b1b415886",bookSignature:"Dimitrios Boskou and Maria Lisa Clodoveo",publishedDate:"October 26th 2016",coverURL:"https://cdn.intechopen.com/books/images_new/5286.jpg",numberOfDownloads:25128,numberOfWosCitations:35,numberOfCrossrefCitations:19,numberOfDimensionsCitations:67,hasAltmetrics:1,numberOfTotalCitations:121,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"November 11th 2015",dateEndSecondStepPublish:"December 2nd 2015",dateEndThirdStepPublish:"March 21st 2016",dateEndFourthStepPublish:"June 19th 2016",dateEndFifthStepPublish:"July 19th 2016",currentStepOfPublishingProcess:5,indexedIn:"1,2,3,4,5,6,8",editedByType:"Edited by",kuFlag:!1,editors:[{id:"77212",title:"Dr.",name:"Dimitrios",middleName:null,surname:"Boskou",slug:"dimitrios-boskou",fullName:"Dimitrios Boskou",profilePictureURL:"https://mts.intechopen.com/storage/users/77212/images/3142_n.jpg",biography:"Dimitrios Boskou received his diploma in chemistry from the School of Chemistry, Aristotle University of Thessaloniki, Hellas; his Philosophy Doctor degree from the University of London, UK; and his degree of Doctor of Science from the School of Chemistry, Aristotle University of Thessaloniki, Hellas. He served as an assistant, lecturer, assistant professor, associate professor, professor and head of the Laboratory of Food Chemistry and Technology, School of Chemistry, Aristotle University of Thessaloniki (1970–2006). From 1986 to 1998, he was a member of the IUPAC Commission on Oils, Fats, and Derivatives. In the years 1995–2005, he served as a member of the Supreme Chemical Council, Athens. From 1995 to 2012, he was a member of the Scientific Committee for Food of the European Commission and a member and expert of the Food Additives Panel of the European Food Safety Authority. His achievements are: over 90 published papers and reviews; author and editor of 8 books; author of 22 chapters in books related to major and minor constituents of fats, natural antioxidants, olive oil and frying of food; and contributor to international scientific encyclopedias and the Lexicon of Lipid Nutrition, a joint IUPAC/IUNS work.",institutionString:null,position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"0",totalChapterViews:"0",totalEditedBooks:"2",institution:null}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,coeditorOne:{id:"199763",title:"Dr.",name:"Maria",middleName:"Lisa",surname:"Clodoveo",slug:"maria-clodoveo",fullName:"Maria Clodoveo",profilePictureURL:"https://mts.intechopen.com/storage/users/199763/images/4896_n.jpg",biography:"Maria Lisa Clodoveo is an assistant professor with tenure at the University of Bari, Italy. \r\n\r\nShe is the director of the short master in 'Health claims of extra virgin olive oil as marketing tool to improve the company’s competitiveness” and deputy director of the postgraduate course in 'Olive Growing Management.” \r\n\r\nShe is a member of the 'Accademia dei Georgofili” and of 'Accademia Nazionale dell’Olivo e dell’Olio.” She is a member of the scientific committee of the international journal Grasas y Aceites. \r\n\r\nShe is the founder of the 'Research Centre for Olive Growing and Olive Oil Industry” at the University of Bari. \r\n\r\nShe is the winner of the award 'Antico Fattore” (2016) assigned by the 'Accademia dei Georgofili” for the innovative approach on virgin olive oil technologies and the award for 'Innovation and applicability” at the International Congress GENP 2016 for the results obtained in the application of ultrasound technology to the virgin olive oil process. \r\n\r\nShe is the inventor of two patents and the author of more than 100 articles and book chapters in the olive oil sector.",institutionString:null,position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"1",totalChapterViews:"0",totalEditedBooks:"0",institution:null},coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"342",title:"Pomology",slug:"pomology"}],chapters:[{id:"51768",title:"Squalene: A Trove of Metabolic Actions",doi:"10.5772/64384",slug:"squalene-a-trove-of-metabolic-actions",totalDownloads:1485,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Adela Ramírez-Torres, Clara Gabás-Rivera and Jesús Osada",downloadPdfUrl:"/chapter/pdf-download/51768",previewPdfUrl:"/chapter/pdf-preview/51768",authors:[{id:"182842",title:"Prof.",name:"Jesus",surname:"Osada",slug:"jesus-osada",fullName:"Jesus Osada"}],corrections:null},{id:"52220",title:"Improvement of Olive Oil Mechanical Extraction: New Technologies, Process Efficiency, and Extra Virgin Olive Oil Quality",doi:"10.5772/64796",slug:"improvement-of-olive-oil-mechanical-extraction-new-technologies-process-efficiency-and-extra-virgin-",totalDownloads:1768,totalCrossrefCites:3,totalDimensionsCites:7,signatures:"Gianluca Veneziani, Beatrice Sordini, Agnese Taticchi, Sonia\nEsposto, Roberto Selvaggini, Stefania Urbani, Ilona Di Maio and\nMaurizio Servili",downloadPdfUrl:"/chapter/pdf-download/52220",previewPdfUrl:"/chapter/pdf-preview/52220",authors:[{id:"183017",title:"Ph.D.",name:"Gianluca",surname:"Veneziani",slug:"gianluca-veneziani",fullName:"Gianluca Veneziani"},{id:"191177",title:"Dr.",name:"Beatrice",surname:"Sordini",slug:"beatrice-sordini",fullName:"Beatrice Sordini"},{id:"191178",title:"Prof.",name:"Agnese",surname:"Taticchi",slug:"agnese-taticchi",fullName:"Agnese Taticchi"},{id:"191179",title:"Dr.",name:"Sonia",surname:"Esposto",slug:"sonia-esposto",fullName:"Sonia Esposto"},{id:"191180",title:"Dr.",name:"Roberto",surname:"Selvaggini",slug:"roberto-selvaggini",fullName:"Roberto Selvaggini"},{id:"191182",title:"Dr.",name:"Stefania",surname:"Urbani",slug:"stefania-urbani",fullName:"Stefania Urbani"},{id:"191183",title:"Dr.",name:"Ilona",surname:"Di Maio",slug:"ilona-di-maio",fullName:"Ilona Di Maio"},{id:"191184",title:"Prof.",name:"Maurizio",surname:"Servili",slug:"maurizio-servili",fullName:"Maurizio Servili"}],corrections:null},{id:"52027",title:"Ultrasound in Olive Oil Extraction",doi:"10.5772/64765",slug:"ultrasound-in-olive-oil-extraction",totalDownloads:1761,totalCrossrefCites:2,totalDimensionsCites:6,signatures:"Riccardo Amirante and Antonello Paduano",downloadPdfUrl:"/chapter/pdf-download/52027",previewPdfUrl:"/chapter/pdf-preview/52027",authors:[{id:"185224",title:"Dr.",name:"Riccardo",surname:"Amirante",slug:"riccardo-amirante",fullName:"Riccardo Amirante"}],corrections:null},{id:"51628",title:"Stabilization of Extra-Virgin Olive Oil",doi:"10.5772/64401",slug:"stabilization-of-extra-virgin-olive-oil",totalDownloads:1463,totalCrossrefCites:0,totalDimensionsCites:4,signatures:"Lorenzo Guerrini and Alessandro Parenti",downloadPdfUrl:"/chapter/pdf-download/51628",previewPdfUrl:"/chapter/pdf-preview/51628",authors:[{id:"183171",title:"Prof.",name:"Alessandro",surname:"Parenti",slug:"alessandro-parenti",fullName:"Alessandro Parenti"},{id:"186912",title:"Dr.",name:"Lorenzo",surname:"Guerrini",slug:"lorenzo-guerrini",fullName:"Lorenzo Guerrini"}],corrections:null},{id:"51857",title:"Chlorophylls and Carotenoids in Food Products from Olive Tree",doi:"10.5772/64688",slug:"chlorophylls-and-carotenoids-in-food-products-from-olive-tree",totalDownloads:1804,totalCrossrefCites:2,totalDimensionsCites:12,signatures:"Beatriz Gandul-Rojas, María Roca and Lourdes Gallardo-Guerrero",downloadPdfUrl:"/chapter/pdf-download/51857",previewPdfUrl:"/chapter/pdf-preview/51857",authors:[{id:"182088",title:"Dr.",name:"Lourdes",surname:"Gallardo-Guerrero",slug:"lourdes-gallardo-guerrero",fullName:"Lourdes Gallardo-Guerrero"},{id:"184804",title:"Dr.",name:"Beatriz",surname:"Gandul-Rojas",slug:"beatriz-gandul-rojas",fullName:"Beatriz Gandul-Rojas"},{id:"184805",title:"Dr.",name:"María",surname:"Roca",slug:"maria-roca",fullName:"María Roca"}],corrections:null},{id:"51827",title:"Pigments in Extra‐Virgin Olive Oil: Authenticity and Quality",doi:"10.5772/64736",slug:"pigments-in-extra-virgin-olive-oil-authenticity-and-quality",totalDownloads:1353,totalCrossrefCites:0,totalDimensionsCites:8,signatures:"Cristina Lazzerini, Mario Cifelli and Valentina Domenici",downloadPdfUrl:"/chapter/pdf-download/51827",previewPdfUrl:"/chapter/pdf-preview/51827",authors:[{id:"182130",title:"Dr.",name:"Valentina",surname:"Domenici",slug:"valentina-domenici",fullName:"Valentina Domenici"},{id:"187809",title:"Dr.",name:"Mario",surname:"Cifelli",slug:"mario-cifelli",fullName:"Mario Cifelli"},{id:"187810",title:"Ms.",name:"Cristina",surname:"Lazzerini",slug:"cristina-lazzerini",fullName:"Cristina Lazzerini"}],corrections:null},{id:"52150",title:"DNA-Based Approaches for Traceability and Authentication of Olive Oil",doi:"10.5772/64494",slug:"dna-based-approaches-for-traceability-and-authentication-of-olive-oil",totalDownloads:1470,totalCrossrefCites:0,totalDimensionsCites:3,signatures:"Christos Bazakos, Stelios Spaniolas and Panagiotis Kalaitzis",downloadPdfUrl:"/chapter/pdf-download/52150",previewPdfUrl:"/chapter/pdf-preview/52150",authors:[{id:"182489",title:"Dr.",name:"Panagiotis",surname:"Kalaitzis",slug:"panagiotis-kalaitzis",fullName:"Panagiotis Kalaitzis"},{id:"183476",title:"Dr.",name:"Christos",surname:"Bazakos",slug:"christos-bazakos",fullName:"Christos Bazakos"},{id:"191691",title:"Dr.",name:"Stelios",surname:"Spaniolas",slug:"stelios-spaniolas",fullName:"Stelios Spaniolas"}],corrections:null},{id:"52514",title:"Evaluation of the “Harmony Value”: A Sensory Method to Discriminate the Quality Range within the Category of EVOO",doi:"10.5772/64727",slug:"evaluation-of-the-harmony-value-a-sensory-method-to-discriminate-the-quality-range-within-the-catego",totalDownloads:1251,totalCrossrefCites:1,totalDimensionsCites:2,signatures:"Annette Bongartz, Martin Popp, Reinhard Schneller and Dieter\nOberg",downloadPdfUrl:"/chapter/pdf-download/52514",previewPdfUrl:"/chapter/pdf-preview/52514",authors:[{id:"181901",title:"Mrs.",name:"Annette",surname:"Bongartz",slug:"annette-bongartz",fullName:"Annette Bongartz"},{id:"184070",title:"Mr.",name:"Dieter",surname:"Oberg",slug:"dieter-oberg",fullName:"Dieter Oberg"},{id:"184071",title:"Mr.",name:"Reinhard",surname:"Schneller",slug:"reinhard-schneller",fullName:"Reinhard Schneller"},{id:"184072",title:"Mr.",name:"Martin",surname:"Popp",slug:"martin-popp",fullName:"Martin Popp"}],corrections:null},{id:"51815",title:"Consumer Perception, Attitudes, Liking and Preferences for Olive Oil",doi:"10.5772/64554",slug:"consumer-perception-attitudes-liking-and-preferences-for-olive-oil",totalDownloads:1337,totalCrossrefCites:1,totalDimensionsCites:4,signatures:"Sara Cicerale, Gie Liem and Russell S.J. Keast",downloadPdfUrl:"/chapter/pdf-download/51815",previewPdfUrl:"/chapter/pdf-preview/51815",authors:[{id:"182960",title:"Dr.",name:"Sara",surname:"Cicerale",slug:"sara-cicerale",fullName:"Sara Cicerale"}],corrections:null},{id:"52085",title:"Olive Oils with Protected Designation of Origin (PDO) and Protected Geographical Indication (PGI)",doi:"10.5772/64909",slug:"olive-oils-with-protected-designation-of-origin-pdo-and-protected-geographical-indication-pgi-",totalDownloads:1821,totalCrossrefCites:4,totalDimensionsCites:11,signatures:"Zisimos Likudis",downloadPdfUrl:"/chapter/pdf-download/52085",previewPdfUrl:"/chapter/pdf-preview/52085",authors:[{id:"183833",title:"Dr.",name:"Zisimos",surname:"Likudis",slug:"zisimos-likudis",fullName:"Zisimos Likudis"}],corrections:null},{id:"51840",title:"Geographical Indication Labels in Moroccan Olive Oil Sector: Territorial Dimension and Characterization of Typicality: A Case Study of Meknès Region",doi:"10.5772/64538",slug:"geographical-indication-labels-in-moroccan-olive-oil-sector-territorial-dimension-and-characterizati",totalDownloads:1112,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Aadil Bajoub, Lucía Olmo-García, Noureddine Ouazzani, Romina\nPaula Monasterio, Gabriel Beltrán and Alegría Carrasco-Pancorbo",downloadPdfUrl:"/chapter/pdf-download/51840",previewPdfUrl:"/chapter/pdf-preview/51840",authors:[{id:"83442",title:"Dr.",name:"Alegria",surname:"Carrasco-Pancorbo",slug:"alegria-carrasco-pancorbo",fullName:"Alegria Carrasco-Pancorbo"},{id:"186812",title:"Mr.",name:"Aadil",surname:"Bajoub",slug:"aadil-bajoub",fullName:"Aadil Bajoub"},{id:"186813",title:"Ms.",name:"Lucia",surname:"Olmo-Garcia",slug:"lucia-olmo-garcia",fullName:"Lucia Olmo-Garcia"},{id:"186814",title:"Dr.",name:"Noureddine",surname:"Ouazzani",slug:"noureddine-ouazzani",fullName:"Noureddine Ouazzani"},{id:"186815",title:"Dr.",name:"Romina Paula",surname:"Monasterio",slug:"romina-paula-monasterio",fullName:"Romina Paula Monasterio"},{id:"186816",title:"Dr.",name:"Gabriel",surname:"Beltran",slug:"gabriel-beltran",fullName:"Gabriel Beltran"}],corrections:null},{id:"52088",title:"Modern Techniques in the Production of Table Olives",doi:"10.5772/64988",slug:"modern-techniques-in-the-production-of-table-olives",totalDownloads:1606,totalCrossrefCites:2,totalDimensionsCites:2,signatures:"Nurcan Değirmencioğlu",downloadPdfUrl:"/chapter/pdf-download/52088",previewPdfUrl:"/chapter/pdf-preview/52088",authors:[{id:"183883",title:"Associate Prof.",name:"Nurcan",surname:"Degirmencioglu",slug:"nurcan-degirmencioglu",fullName:"Nurcan Degirmencioglu"}],corrections:null},{id:"51828",title:"Biotechnology can Improve a Traditional Product as Table Olives",doi:"10.5772/64687",slug:"biotechnology-can-improve-a-traditional-product-as-table-olives",totalDownloads:1416,totalCrossrefCites:0,totalDimensionsCites:1,signatures:"Maria Tufariello, Giovanni Mita and Gianluca Bleve",downloadPdfUrl:"/chapter/pdf-download/51828",previewPdfUrl:"/chapter/pdf-preview/51828",authors:[{id:"182471",title:"Dr.",name:"Gianluca",surname:"Bleve",slug:"gianluca-bleve",fullName:"Gianluca Bleve"}],corrections:null},{id:"52440",title:"The Possibility of Recovering of Hydroxytyrosol from Olive Milling Wastewater by Enzymatic Bioconversion",doi:"10.5772/64774",slug:"the-possibility-of-recovering-of-hydroxytyrosol-from-olive-milling-wastewater-by-enzymatic-bioconver",totalDownloads:1339,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Manel Hamza and Sami Sayadi",downloadPdfUrl:"/chapter/pdf-download/52440",previewPdfUrl:"/chapter/pdf-preview/52440",authors:[{id:"183101",title:"Dr.",name:"Manel",surname:"Hamza",slug:"manel-hamza",fullName:"Manel Hamza"}],corrections:null},{id:"51966",title:"A Brief Review on Recent Processes for the Treatment of Olive Mill Effluents",doi:"10.5772/64798",slug:"a-brief-review-on-recent-processes-for-the-treatment-of-olive-mill-effluents",totalDownloads:1529,totalCrossrefCites:0,totalDimensionsCites:0,signatures:"Javier Miguel Ochando‐Pulido, Rita Fragoso, Antónia Macedo,\nElizabeth Duarte and Antonio Martínez Ferez",downloadPdfUrl:"/chapter/pdf-download/51966",previewPdfUrl:"/chapter/pdf-preview/51966",authors:[{id:"183540",title:"Dr.",name:"Javier Miguel",surname:"Ochando Pulido",slug:"javier-miguel-ochando-pulido",fullName:"Javier Miguel Ochando Pulido"}],corrections:null},{id:"51671",title:"Olive Oil in Brazil: Economic and Regulatory Control Aspects",doi:"10.5772/64539",slug:"olive-oil-in-brazil-economic-and-regulatory-control-aspects",totalDownloads:1264,totalCrossrefCites:1,totalDimensionsCites:1,signatures:"Sabria Aued-Pimentel",downloadPdfUrl:"/chapter/pdf-download/51671",previewPdfUrl:"/chapter/pdf-preview/51671",authors:[{id:"183238",title:"Dr.",name:"Sabria",surname:"Aued-Pimentel",slug:"sabria-aued-pimentel",fullName:"Sabria Aued-Pimentel"}],corrections:null},{id:"52019",title:"Tocopherols: Chemical Structure, Bioactivity, and Variability in Croatian Virgin Olive Oils",doi:"10.5772/64658",slug:"tocopherols-chemical-structure-bioactivity-and-variability-in-croatian-virgin-olive-oils",totalDownloads:1352,totalCrossrefCites:3,totalDimensionsCites:6,signatures:"Maja Jukić Špika, Klara Kraljić and Dubravka Škevin",downloadPdfUrl:"/chapter/pdf-download/52019",previewPdfUrl:"/chapter/pdf-preview/52019",authors:[{id:"183357",title:"Dr.",name:"Maja",surname:"Jukić Špika",slug:"maja-jukic-spika",fullName:"Maja Jukić Špika"},{id:"188382",title:"Dr.",name:"Klara",surname:"Kraljić",slug:"klara-kraljic",fullName:"Klara Kraljić"},{id:"188383",title:"Prof.",name:"Dubravka",surname:"Škevin",slug:"dubravka-skevin",fullName:"Dubravka Škevin"}],corrections:null}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},relatedBooks:[{type:"book",id:"869",title:"Olive Oil",subtitle:"Constituents, Quality, Health Properties and Bioconversions",isOpenForSubmission:!1,hash:"b26e27a335ddfd64f9583593dbd8ceb5",slug:"olive-oil-constituents-quality-health-properties-and-bioconversions",bookSignature:"Boskou Dimitrios",coverURL:"https://cdn.intechopen.com/books/images_new/869.jpg",editedByType:"Edited by",editors:[{id:"77212",title:"Dr.",name:"Dimitrios",surname:"Boskou",slug:"dimitrios-boskou",fullName:"Dimitrios Boskou"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"2986",title:"Olive Germplasm",subtitle:"The Olive Cultivation, Table Olive and Olive Oil Industry in Italy",isOpenForSubmission:!1,hash:"e38f87edf2aa3a482b19c336008b89ea",slug:"olive-germplasm-the-olive-cultivation-table-olive-and-olive-oil-industry-in-italy",bookSignature:"Innocenzo Muzzalupo",coverURL:"https://cdn.intechopen.com/books/images_new/2986.jpg",editedByType:"Edited by",editors:[{id:"93139",title:"Dr.",name:"Innocenzo",surname:"Muzzalupo",slug:"innocenzo-muzzalupo",fullName:"Innocenzo Muzzalupo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"3",chapterContentType:"chapter",authoredCaption:"Authored by"}},{type:"book",id:"3577",title:"Olive Germplasm",subtitle:"Italian Catalogue of Olive Varieties",isOpenForSubmission:!1,hash:"cc6525c8fb7f4191b5f6ea035a7893e5",slug:"olive-germplasm-italian-catalogue-of-olive-varieties",bookSignature:"Innocenzo Muzzalupo",coverURL:"https://cdn.intechopen.com/books/images_new/3577.jpg",editedByType:"Authored by",editors:[{id:"93139",title:"Dr.",name:"Innocenzo",surname:"Muzzalupo",slug:"innocenzo-muzzalupo",fullName:"Innocenzo Muzzalupo"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"3",chapterContentType:"chapter",authoredCaption:"Authored by"}},{type:"book",id:"5972",title:"Postharvest Handling",subtitle:null,isOpenForSubmission:!1,hash:"68eb74526fe2b5a328ad537425137a0d",slug:"postharvest-handling",bookSignature:"Ibrahim Kahramanoglu",coverURL:"https://cdn.intechopen.com/books/images_new/5972.jpg",editedByType:"Edited by",editors:[{id:"178185",title:"Ph.D.",name:"Ibrahim",surname:"Kahramanoglu",slug:"ibrahim-kahramanoglu",fullName:"Ibrahim Kahramanoglu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"8152",title:"Modern Fruit Industry",subtitle:null,isOpenForSubmission:!1,hash:"4ea4aff1aa2988e552a7a8ff3384c59a",slug:"modern-fruit-industry",bookSignature:"Ibrahim Kahramanoglu, Nesibe Ebru Kafkas, Ayzin Küden and Songül Çömlekçioğlu",coverURL:"https://cdn.intechopen.com/books/images_new/8152.jpg",editedByType:"Edited by",editors:[{id:"178185",title:"Ph.D.",name:"Ibrahim",surname:"Kahramanoglu",slug:"ibrahim-kahramanoglu",fullName:"Ibrahim Kahramanoglu"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"6996",title:"Strawberry",subtitle:"Pre- and Post-Harvest Management Techniques for Higher Fruit Quality",isOpenForSubmission:!1,hash:"dc740162f400a4dd3e9377a140424917",slug:"strawberry-pre-and-post-harvest-management-techniques-for-higher-fruit-quality",bookSignature:"Toshiki Asao and Md Asaduzzaman",coverURL:"https://cdn.intechopen.com/books/images_new/6996.jpg",editedByType:"Edited by",editors:[{id:"106510",title:"Dr.",name:"Toshiki",surname:"Asao",slug:"toshiki-asao",fullName:"Toshiki Asao"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophanides",surname:"Theophile",slug:"theophanides-theophile",fullName:"Theophanides Theophile"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}],ofsBooks:[]},correction:{item:{id:"72181",slug:"corrigendum-to-potassium-channels-as-a-potential-target-spot-for-drugs",title:"Corrigendum to: Potassium Channels as a Potential Target Spot for Drugs",doi:null,correctionPDFUrl:"https://cdn.intechopen.com/pdfs/72181.pdf",downloadPdfUrl:"/chapter/pdf-download/72181",previewPdfUrl:"/chapter/pdf-preview/72181",totalDownloads:null,totalCrossrefCites:null,bibtexUrl:"/chapter/bibtex/72181",risUrl:"/chapter/ris/72181",chapter:{id:"71907",slug:"potassium-channels-as-a-potential-target-spot-for-drugs",signatures:"Vladimir Djokic and Radmila Novakovic",dateSubmitted:"October 13th 2019",dateReviewed:"March 18th 2020",datePrePublished:"April 28th 2020",datePublished:"December 16th 2020",book:{id:"10143",title:"Molecular Pharmacology",subtitle:null,fullTitle:"Molecular Pharmacology",slug:"molecular-pharmacology",publishedDate:"December 16th 2020",bookSignature:"Angel Catala and Usama Ahmad",coverURL:"https://cdn.intechopen.com/books/images_new/10143.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"196544",title:"Prof.",name:"Angel",middleName:null,surname:"Catala",slug:"angel-catala",fullName:"Angel Catala"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"313382",title:"Ph.D.",name:"Radmila",middleName:null,surname:"Novakovic",fullName:"Radmila Novakovic",slug:"radmila-novakovic",email:"radmila.novakovic@med.bg.ac.rs",position:null,institution:null}]}},chapter:{id:"71907",slug:"potassium-channels-as-a-potential-target-spot-for-drugs",signatures:"Vladimir Djokic and Radmila Novakovic",dateSubmitted:"October 13th 2019",dateReviewed:"March 18th 2020",datePrePublished:"April 28th 2020",datePublished:"December 16th 2020",book:{id:"10143",title:"Molecular Pharmacology",subtitle:null,fullTitle:"Molecular Pharmacology",slug:"molecular-pharmacology",publishedDate:"December 16th 2020",bookSignature:"Angel Catala and Usama Ahmad",coverURL:"https://cdn.intechopen.com/books/images_new/10143.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"196544",title:"Prof.",name:"Angel",middleName:null,surname:"Catala",slug:"angel-catala",fullName:"Angel Catala"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}},authors:[{id:"313382",title:"Ph.D.",name:"Radmila",middleName:null,surname:"Novakovic",fullName:"Radmila Novakovic",slug:"radmila-novakovic",email:"radmila.novakovic@med.bg.ac.rs",position:null,institution:null}]},book:{id:"10143",title:"Molecular Pharmacology",subtitle:null,fullTitle:"Molecular Pharmacology",slug:"molecular-pharmacology",publishedDate:"December 16th 2020",bookSignature:"Angel Catala and Usama Ahmad",coverURL:"https://cdn.intechopen.com/books/images_new/10143.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"196544",title:"Prof.",name:"Angel",middleName:null,surname:"Catala",slug:"angel-catala",fullName:"Angel Catala"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"}}},ofsBook:{item:{type:"book",id:"10219",leadTitle:null,title:"Fundamentals of Glycosylation",subtitle:null,reviewType:"peer-reviewed",abstract:"\r\n\tGlycosylation is an important and very precisely regulated biological event of protein processing within the cellular environment. This mega event plays a crucial role in ascertaining protein structure, function, fate, and ligand-receptor association. The glycosylation process also has a significant role in several human diseases. The present book will provide deep insights into non-enzymatic glycosylation events in the cells and how biomacromolecules like proteins, lipids, and nucleic acids get affected by this event.
\r\n\r\n\tThis book also puts light on the various categories of glycosylation like N-linked, O-linked, C-linked, and phosphoserine glycosylation events that are involved in disease biology and its pathogenesis. The frontier part of this book gives newer treatment approaches by targeting glycosylation to treat human diseases like diabetes and its associated micro-vascular and macro-vascular complication, cancer, viral hepatitis B, Gaucher disease, etc. This book will provide a complete package of glycosylation fundamentals for the healthcare system, clinicians, and researchers.
",isbn:"978-1-83969-135-5",printIsbn:"978-1-83969-134-8",pdfIsbn:"978-1-83969-136-2",doi:null,price:0,priceEur:0,priceUsd:0,slug:null,numberOfPages:0,isOpenForSubmission:!0,hash:"f1f82214d3d5460d3b52c4d8e87e3858",bookSignature:"Dr. Alok Raghav and Dr. Jamal Ahmad",publishedDate:null,coverURL:"https://cdn.intechopen.com/books/images_new/10219.jpg",keywords:"N Linked, O Linked, C Linked, Nucleic Acids, Proteins, Lipids, Diabetes Mellitus, Diabetic Retinopathy, Diabetic Nephropathy, Cancer, Hepatitis B, Gaucher Disease",numberOfDownloads:null,numberOfWosCitations:0,numberOfCrossrefCitations:null,numberOfDimensionsCitations:null,numberOfTotalCitations:null,isAvailableForWebshopOrdering:!0,dateEndFirstStepPublish:"November 23rd 2020",dateEndSecondStepPublish:"December 21st 2020",dateEndThirdStepPublish:"February 19th 2021",dateEndFourthStepPublish:"May 10th 2021",dateEndFifthStepPublish:"July 9th 2021",remainingDaysToSecondStep:"a month",secondStepPassed:!0,currentStepOfPublishingProcess:3,editedByType:null,kuFlag:!1,biosketch:"Dr. Alok Raghav is a motivational, visionary independent researcher with a meticulous understanding of glycosylation, holding editorial positions in reputed International journals, and an honorary fellow of the Indian Association of Nanoscience and Nanotechnology. His research focuses on designing new targets against glycosylation using a nanotechnology approach to treat human diseases.",coeditorOneBiosketch:"Dr. Jamal Ahmad is an expert endocrinologist equipped with knowledge and experience of diabetes and its understanding. He is a former Dean Faculty of Medicine and a recipient of the RSSDI award, and a Lifetime Achievement Award by Diabetes India 2019. He has made a significant contribution toward determining the role of protein glycation in diabetes and its associated complications.",coeditorTwoBiosketch:null,coeditorThreeBiosketch:null,coeditorFourBiosketch:null,coeditorFiveBiosketch:null,editors:[{id:"334465",title:"Dr.",name:"Alok",middleName:null,surname:"Raghav",slug:"alok-raghav",fullName:"Alok Raghav",profilePictureURL:"https://mts.intechopen.com/storage/users/334465/images/system/334465.jpg",biography:"Alok Raghav is an Research Scientist at Multidisciplinary Research Unit, Ganesh Shankar Vidyarthi Medical College, Kanpur, India. He has completed his PhD and postdoctorate research on albumin protein glycation in diabetes and its associated complications and has extensive research experience in the field of medical science and healthcare. His research focuses on the designing new targets against glycosylation using nanotechnology approach. to treat human diseases. He has published more than 40 research papers in International peer reviewed journals and has presented his work at various reputed national and International conferences. He is also recipient of prestigious Endocrine Society Award, USA and honorary fellow of Indian Association of Nanoscience and Nanotechnology. He is serving as reviewer and editorial board member of several International Journals.",institutionString:"Ganesh Shankar Vidyarthi Memorial Medical College",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"0",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Ganesh Shankar Vidyarthi Memorial Medical College",institutionURL:null,country:{name:"India"}}}],coeditorOne:{id:"335336",title:"Dr.",name:"Jamal",middleName:null,surname:"Ahmad",slug:"jamal-ahmad",fullName:"Jamal Ahmad",profilePictureURL:"https://mts.intechopen.com/storage/users/no_image.jpg",biography:null,institutionString:"Aligarh Muslim University",position:null,outsideEditionCount:0,totalCites:0,totalAuthoredChapters:"0",totalChapterViews:"0",totalEditedBooks:"0",institution:{name:"Aligarh Muslim University",institutionURL:null,country:{name:"India"}}},coeditorTwo:null,coeditorThree:null,coeditorFour:null,coeditorFive:null,topics:[{id:"6",title:"Biochemistry, Genetics and Molecular Biology",slug:"biochemistry-genetics-and-molecular-biology"}],chapters:null,productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},personalPublishingAssistant:{id:"205697",firstName:"Kristina",lastName:"Kardum Cvitan",middleName:null,title:"Ms.",imageUrl:"https://mts.intechopen.com/storage/users/205697/images/5186_n.jpg",email:"kristina.k@intechopen.com",biography:"As an Author Service Manager my responsibilities include monitoring and facilitating all publishing activities for authors and editors. From chapter submission and review, to approval and revision, copyediting and design, until final publication, I work closely with authors and editors to ensure a simple and easy publishing process. I maintain constant and effective communication with authors, editors and reviewers, which allows for a level of personal support that enables contributors to fully commit and concentrate on the chapters they are writing, editing, or reviewing. I assist authors in the preparation of their full chapter submissions and track important deadlines and ensure they are met. I help to coordinate internal processes such as linguistic review, and monitor the technical aspects of the process. As an ASM I am also involved in the acquisition of editors. Whether that be identifying an exceptional author and proposing an editorship collaboration, or contacting researchers who would like the opportunity to work with IntechOpen, I establish and help manage author and editor acquisition and contact."}},relatedBooks:[{type:"book",id:"6694",title:"New Trends in Ion Exchange Studies",subtitle:null,isOpenForSubmission:!1,hash:"3de8c8b090fd8faa7c11ec5b387c486a",slug:"new-trends-in-ion-exchange-studies",bookSignature:"Selcan Karakuş",coverURL:"https://cdn.intechopen.com/books/images_new/6694.jpg",editedByType:"Edited by",editors:[{id:"206110",title:"Dr.",name:"Selcan",surname:"Karakuş",slug:"selcan-karakus",fullName:"Selcan Karakuş"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1591",title:"Infrared Spectroscopy",subtitle:"Materials Science, Engineering and Technology",isOpenForSubmission:!1,hash:"99b4b7b71a8caeb693ed762b40b017f4",slug:"infrared-spectroscopy-materials-science-engineering-and-technology",bookSignature:"Theophile Theophanides",coverURL:"https://cdn.intechopen.com/books/images_new/1591.jpg",editedByType:"Edited by",editors:[{id:"37194",title:"Dr.",name:"Theophanides",surname:"Theophile",slug:"theophanides-theophile",fullName:"Theophanides Theophile"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3092",title:"Anopheles mosquitoes",subtitle:"New insights into malaria vectors",isOpenForSubmission:!1,hash:"c9e622485316d5e296288bf24d2b0d64",slug:"anopheles-mosquitoes-new-insights-into-malaria-vectors",bookSignature:"Sylvie Manguin",coverURL:"https://cdn.intechopen.com/books/images_new/3092.jpg",editedByType:"Edited by",editors:[{id:"50017",title:"Prof.",name:"Sylvie",surname:"Manguin",slug:"sylvie-manguin",fullName:"Sylvie Manguin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"3161",title:"Frontiers in Guided Wave Optics and Optoelectronics",subtitle:null,isOpenForSubmission:!1,hash:"deb44e9c99f82bbce1083abea743146c",slug:"frontiers-in-guided-wave-optics-and-optoelectronics",bookSignature:"Bishnu Pal",coverURL:"https://cdn.intechopen.com/books/images_new/3161.jpg",editedByType:"Edited by",editors:[{id:"4782",title:"Prof.",name:"Bishnu",surname:"Pal",slug:"bishnu-pal",fullName:"Bishnu Pal"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"72",title:"Ionic Liquids",subtitle:"Theory, Properties, New Approaches",isOpenForSubmission:!1,hash:"d94ffa3cfa10505e3b1d676d46fcd3f5",slug:"ionic-liquids-theory-properties-new-approaches",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/72.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"1373",title:"Ionic Liquids",subtitle:"Applications and Perspectives",isOpenForSubmission:!1,hash:"5e9ae5ae9167cde4b344e499a792c41c",slug:"ionic-liquids-applications-and-perspectives",bookSignature:"Alexander Kokorin",coverURL:"https://cdn.intechopen.com/books/images_new/1373.jpg",editedByType:"Edited by",editors:[{id:"19816",title:"Prof.",name:"Alexander",surname:"Kokorin",slug:"alexander-kokorin",fullName:"Alexander Kokorin"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"57",title:"Physics and Applications of Graphene",subtitle:"Experiments",isOpenForSubmission:!1,hash:"0e6622a71cf4f02f45bfdd5691e1189a",slug:"physics-and-applications-of-graphene-experiments",bookSignature:"Sergey Mikhailov",coverURL:"https://cdn.intechopen.com/books/images_new/57.jpg",editedByType:"Edited by",editors:[{id:"16042",title:"Dr.",name:"Sergey",surname:"Mikhailov",slug:"sergey-mikhailov",fullName:"Sergey Mikhailov"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"371",title:"Abiotic Stress in Plants",subtitle:"Mechanisms and Adaptations",isOpenForSubmission:!1,hash:"588466f487e307619849d72389178a74",slug:"abiotic-stress-in-plants-mechanisms-and-adaptations",bookSignature:"Arun Shanker and B. Venkateswarlu",coverURL:"https://cdn.intechopen.com/books/images_new/371.jpg",editedByType:"Edited by",editors:[{id:"58592",title:"Dr.",name:"Arun",surname:"Shanker",slug:"arun-shanker",fullName:"Arun Shanker"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"878",title:"Phytochemicals",subtitle:"A Global Perspective of Their Role in Nutrition and Health",isOpenForSubmission:!1,hash:"ec77671f63975ef2d16192897deb6835",slug:"phytochemicals-a-global-perspective-of-their-role-in-nutrition-and-health",bookSignature:"Venketeshwer Rao",coverURL:"https://cdn.intechopen.com/books/images_new/878.jpg",editedByType:"Edited by",editors:[{id:"82663",title:"Dr.",name:"Venketeshwer",surname:"Rao",slug:"venketeshwer-rao",fullName:"Venketeshwer Rao"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}},{type:"book",id:"4816",title:"Face Recognition",subtitle:null,isOpenForSubmission:!1,hash:"146063b5359146b7718ea86bad47c8eb",slug:"face_recognition",bookSignature:"Kresimir Delac and Mislav Grgic",coverURL:"https://cdn.intechopen.com/books/images_new/4816.jpg",editedByType:"Edited by",editors:[{id:"528",title:"Dr.",name:"Kresimir",surname:"Delac",slug:"kresimir-delac",fullName:"Kresimir Delac"}],productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"}}]},chapter:{item:{type:"chapter",id:"31353",title:"The Impact of Macrophage Membrane Lipid Composition on Innate Immune Response Mechanisms",doi:"10.5772/25297",slug:"the-impact-of-macrophage-membrane-lipid-composition-on-innate-immune-response-mechanisms",body:null,keywords:null,chapterPDFUrl:"https://cdn.intechopen.com/pdfs/31353.pdf",chapterXML:null,downloadPdfUrl:"/chapter/pdf-download/31353",previewPdfUrl:"/chapter/pdf-preview/31353",totalDownloads:2881,totalViews:146,totalCrossrefCites:1,totalDimensionsCites:3,hasAltmetrics:0,dateSubmitted:"January 20th 2011",dateReviewed:"April 8th 2011",datePrePublished:null,datePublished:"March 9th 2012",dateFinished:null,readingETA:"0",abstract:null,reviewType:"peer-reviewed",bibtexUrl:"/chapter/bibtex/31353",risUrl:"/chapter/ris/31353",book:{slug:"inflammation-chronic-diseases-and-cancer-cell-and-molecular-biology-immunology-and-clinical-bases"},signatures:"Julia Schumann",authors:[{id:"62908",title:"Dr.",name:"Julia",middleName:null,surname:"Schumann",fullName:"Julia Schumann",slug:"julia-schumann",email:"julia.schumann@vmf.uni-leipzig.de",position:null,institution:null}],sections:null,chapterReferences:null,footnotes:null,contributors:null,corrections:null},book:{id:"710",title:"Inflammation, Chronic Diseases and Cancer",subtitle:"Cell and Molecular Biology, Immunology and Clinical Bases",fullTitle:"Inflammation, Chronic Diseases and Cancer - Cell and Molecular Biology, Immunology and Clinical Bases",slug:"inflammation-chronic-diseases-and-cancer-cell-and-molecular-biology-immunology-and-clinical-bases",publishedDate:"March 9th 2012",bookSignature:"Mahin Khatami",coverURL:"https://cdn.intechopen.com/books/images_new/710.jpg",licenceType:"CC BY 3.0",editedByType:"Edited by",editors:[{id:"63956",title:"Dr.",name:"Mahin",middleName:null,surname:"Khatami",slug:"mahin-khatami",fullName:"Mahin Khatami"}],productType:{id:"1",title:"Edited Volume",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"31352",title:"Inflammation, Aging and Cancer: Friend or Foe?",slug:"inflammation-aging-and-cancer-friend-or-foe-",totalDownloads:3104,totalCrossrefCites:0,signatures:"Mahin Khatami",authors:[{id:"63956",title:"Dr.",name:"Mahin",middleName:null,surname:"Khatami",fullName:"Mahin Khatami",slug:"mahin-khatami"}]},{id:"31353",title:"The Impact of Macrophage Membrane Lipid Composition on Innate Immune Response Mechanisms",slug:"the-impact-of-macrophage-membrane-lipid-composition-on-innate-immune-response-mechanisms",totalDownloads:2881,totalCrossrefCites:1,signatures:"Julia Schumann",authors:[{id:"62908",title:"Dr.",name:"Julia",middleName:null,surname:"Schumann",fullName:"Julia Schumann",slug:"julia-schumann"}]},{id:"31354",title:"The Innate Immune Response Mediated by TLRs in Atherosclerosis",slug:"the-innate-immune-response-mediated-by-tlrs-in-atherosclerosis",totalDownloads:2878,totalCrossrefCites:0,signatures:"Luis Chávez-Sánchez, Karina Chávez-Rueda, María Victoria Legorreta-Haquet, Eduardo Montoya-Díaz and Francisco Blanco-Favela",authors:[{id:"63952",title:"Dr.",name:"Francisco",middleName:null,surname:"Blanco-Favela",fullName:"Francisco Blanco-Favela",slug:"francisco-blanco-favela"},{id:"68561",title:"Prof.",name:"Luis",middleName:null,surname:"Chávez-Sánchez",fullName:"Luis Chávez-Sánchez",slug:"luis-chavez-sanchez"},{id:"68976",title:"Dr.",name:"Karina",middleName:null,surname:"Chavez-Rueda",fullName:"Karina Chavez-Rueda",slug:"karina-chavez-rueda"},{id:"68977",title:"MSc",name:"María Victoria",middleName:null,surname:"Legorreta-Haquet",fullName:"María Victoria Legorreta-Haquet",slug:"maria-victoria-legorreta-haquet"},{id:"68979",title:"MSc.",name:"Eduardo",middleName:null,surname:"Montoya-Díaz",fullName:"Eduardo Montoya-Díaz",slug:"eduardo-montoya-diaz"}]},{id:"31355",title:"Autoimmunity, Atherosclerosis and Apoptotic Cell Clearance",slug:"autoimmunity-apoptosis-and-accelerated-atherosclerosis",totalDownloads:2178,totalCrossrefCites:0,signatures:"Tamar Aprahamian",authors:[{id:"63784",title:"Dr.",name:"Tamar",middleName:null,surname:"Aprahamian",fullName:"Tamar Aprahamian",slug:"tamar-aprahamian"}]},{id:"31356",title:"The Platelet as an Immunomodulator: The Old Thespian with New Roles in Atherosclerosis, Sepsis and Autoimmune Disease",slug:"the-platelet-as-an-immunomodulator-the-old-thespian-with-new-roles-in-atherosclerosis-sepsis-and-aut",totalDownloads:2351,totalCrossrefCites:0,signatures:"Omar L. Esponda, Yaliz Loperena, Gladiany Ramos and A. Valance Washington",authors:[{id:"64298",title:"Dr.",name:"A. Valance",middleName:null,surname:"Washington",fullName:"A. Valance Washington",slug:"a.-valance-washington"},{id:"70195",title:"Dr",name:"Omar",middleName:"Lazaro",surname:"Esponda",fullName:"Omar Esponda",slug:"omar-esponda"},{id:"70198",title:"MSc.",name:"Yaliz",middleName:null,surname:"Loperena",fullName:"Yaliz Loperena",slug:"yaliz-loperena"},{id:"70200",title:"BSc.",name:"Gladiany",middleName:null,surname:"Ramos",fullName:"Gladiany Ramos",slug:"gladiany-ramos"}]},{id:"31357",title:"Regulatory T Cells and Viral Disease",slug:"regulatory-t-cells-and-viral-disease",totalDownloads:2788,totalCrossrefCites:1,signatures:"Tanya LeRoith and S. Ansar Ahmed",authors:[{id:"74091",title:"Dr.",name:"Tanya",middleName:null,surname:"LeRoith",fullName:"Tanya LeRoith",slug:"tanya-leroith"}]},{id:"31358",title:"Inflammation, Immunity and Redox Signaling",slug:"inflammation-immunity-and-redox-signaling",totalDownloads:3788,totalCrossrefCites:2,signatures:"Joshua Jabaut and Karina Ckless",authors:[{id:"69397",title:"Dr.",name:"Karina",middleName:null,surname:"Ckless",fullName:"Karina Ckless",slug:"karina-ckless"},{id:"69405",title:"MSc.",name:"Joshua",middleName:null,surname:"Jabaut",fullName:"Joshua Jabaut",slug:"joshua-jabaut"}]},{id:"31359",title:"Complement Receptors in Inflammation",slug:"complement-receptors-in-inflammation",totalDownloads:3197,totalCrossrefCites:0,signatures:"Priyanka Pundir and Marianna Kulka",authors:[{id:"63882",title:"Dr.",name:"Marianna",middleName:null,surname:"Kulka",fullName:"Marianna Kulka",slug:"marianna-kulka"},{id:"125891",title:"Dr.",name:"Priyanka",middleName:null,surname:"Pundir",fullName:"Priyanka Pundir",slug:"priyanka-pundir"}]},{id:"31360",title:"Parasitic Infections and Inflammatory Diseases",slug:"parasitic-infections-and-inflammatory-diseases",totalDownloads:4832,totalCrossrefCites:0,signatures:"Joziana M.P. Barçante, Thales A. Barçante, Ana Paula Peconick, Luciano J. Pereira and Walter S. Lima",authors:[{id:"64263",title:"Prof.",name:"Joziana",middleName:"Muniz De Paiva",surname:"Barçante",fullName:"Joziana Barçante",slug:"joziana-barcante"},{id:"64267",title:"Prof.",name:"Thales",middleName:"Augusto",surname:"Barçante",fullName:"Thales Barçante",slug:"thales-barcante"},{id:"67878",title:"Prof.",name:"Walter",middleName:null,surname:"Lima",fullName:"Walter Lima",slug:"walter-lima"},{id:"92272",title:"Prof.",name:"Ana",middleName:"Paula",surname:"Peconick",fullName:"Ana Peconick",slug:"ana-peconick"},{id:"92409",title:"Prof.",name:"Luciano",middleName:null,surname:"Pereira",fullName:"Luciano Pereira",slug:"luciano-pereira"}]},{id:"31361",title:"The Role of Chemokines and Cytokines in the Pathogenesis of Periodontal and Periapical Lesions: Current Concepts",slug:"the-role-of-chemokines-and-cytokines-in-the-pathogenesis-of-periodontal-and-periapical-lesions-curre",totalDownloads:5428,totalCrossrefCites:1,signatures:"Gustavo P. Garlet, Andreza M.F. Aranha, Elcia M. Silveira, Andreia Espindola Vieira, Celso M. Queiroz-Junior, Mila F.M. Madeira, Sandra Y. Fukada and Tarcilia A. Silva",authors:[{id:"69448",title:"Dr.",name:"Tarcilia",middleName:null,surname:"Silva",fullName:"Tarcilia Silva",slug:"tarcilia-silva"},{id:"70047",title:"Prof.",name:"Gustavo",middleName:null,surname:"Garlet",fullName:"Gustavo Garlet",slug:"gustavo-garlet"},{id:"70050",title:"Prof.",name:"Sandra",middleName:null,surname:"Fukada",fullName:"Sandra Fukada",slug:"sandra-fukada"},{id:"70052",title:"Dr.",name:"Celso",middleName:null,surname:"Queiroz-Junior",fullName:"Celso Queiroz-Junior",slug:"celso-queiroz-junior"},{id:"70056",title:"Dr.",name:"Mila",middleName:null,surname:"Madeira",fullName:"Mila Madeira",slug:"mila-madeira"},{id:"70058",title:"Dr.",name:"Andreza",middleName:null,surname:"Aranha",fullName:"Andreza Aranha",slug:"andreza-aranha"},{id:"70062",title:"Dr.",name:"Elcia",middleName:null,surname:"Silveira",fullName:"Elcia Silveira",slug:"elcia-silveira"},{id:"118143",title:"Dr.",name:"Andreia",middleName:null,surname:"Vieira",fullName:"Andreia Vieira",slug:"andreia-vieira"}]},{id:"31362",title:"Involvement of Microglial Cathepsin B in Pro-Interleukin-1 Processing and Persistent Pain",slug:"cathepsin-b-in-neuroinflammation-and-pain",totalDownloads:1998,totalCrossrefCites:0,signatures:"Hiroshi Nakanishi",authors:[{id:"63049",title:"Prof.",name:"Hiroshi",middleName:null,surname:"Nakanishi",fullName:"Hiroshi Nakanishi",slug:"hiroshi-nakanishi"}]},{id:"31363",title:"Review of Cytomegalovirus Anterior Uveitis",slug:"review-of-cytomegalovirus-anterior-uveitis-",totalDownloads:3675,totalCrossrefCites:1,signatures:"C. E. Pang",authors:[{id:"63656",title:"Dr.",name:"C. E.",middleName:null,surname:"Pang",fullName:"C. E. Pang",slug:"c.-e.-pang"}]},{id:"31364",title:"“Suppressor of Cytokine Signalling” Molecules in Infection and Inflammation",slug:"socs-molecules-in-infection-and-inflammation",totalDownloads:2046,totalCrossrefCites:0,signatures:"Berit Carow and Martin E. Rottenberg",authors:[{id:"65192",title:"Dr.",name:"Martin",middleName:null,surname:"Rottenberg",fullName:"Martin Rottenberg",slug:"martin-rottenberg"},{id:"66900",title:"MSc.",name:"Berit",middleName:null,surname:"Carow",fullName:"Berit Carow",slug:"berit-carow"}]},{id:"31365",title:"Role of the Neutrophil NADPH Oxidase and S100A8/A9 in the Pathophysiology of Chronic Inflammation",slug:"role-of-the-neutrophil-nadph-oxidase-and-s100a8-a9-in-the-pathophysiology-of-chronic-inflammation",totalDownloads:2179,totalCrossrefCites:0,signatures:"Sabrina Bréchard, Véronique Schenten and Eric J. Tschirhart",authors:[{id:"65173",title:"Dr.",name:"Sabrina",middleName:null,surname:"Brechard",fullName:"Sabrina Brechard",slug:"sabrina-brechard"},{id:"74289",title:"Prof.",name:"Eric",middleName:"J",surname:"Tschirhart",fullName:"Eric Tschirhart",slug:"eric-tschirhart"},{id:"120120",title:"Dr.",name:"Véronique",middleName:null,surname:"Schenten",fullName:"Véronique Schenten",slug:"veronique-schenten"}]},{id:"31366",title:"Inflammation in COPD and New Drug Strategies",slug:"inflammation-in-chronic-obstructive-pulmonary-disease-implications-for-new-treatment-strategies",totalDownloads:3370,totalCrossrefCites:0,signatures:"Liam Heaney and Izhaq Masih",authors:[{id:"70453",title:"Prof.",name:"Liam",middleName:null,surname:"Heaney",fullName:"Liam Heaney",slug:"liam-heaney"},{id:"70816",title:"Dr.",name:"Izhaq",middleName:null,surname:"Masih",fullName:"Izhaq Masih",slug:"izhaq-masih"}]},{id:"31367",title:"Malnutrition and Inflammation",slug:"malnutrition-and-inflammation",totalDownloads:4133,totalCrossrefCites:0,signatures:"Jorge R. Mujico, Fátima Pérez-de-Heredia, Sonia Gómez-Martínez and Ascensión Marcos",authors:[{id:"62998",title:"Dr",name:"Ascensión",middleName:null,surname:"Marcos",fullName:"Ascensión Marcos",slug:"ascension-marcos"},{id:"74499",title:"Dr.",name:"Jorge",middleName:"Raul",surname:"Mujico",fullName:"Jorge Mujico",slug:"jorge-mujico"},{id:"74500",title:"Dr",name:"Fátima",middleName:null,surname:"Pérez De Heredia",fullName:"Fátima Pérez De Heredia",slug:"fatima-perez-de-heredia"},{id:"74501",title:"Dr",name:"Sonia",middleName:null,surname:"Gómez-Martínez",fullName:"Sonia Gómez-Martínez",slug:"sonia-gomez-martinez"}]},{id:"31368",title:"Anti-CXCL13 and Anti-TNFα Monoclonal Antibodies Combinatorial Treatment Inhibits Autoimmune Disease in a Murine Model of Systemic Lupus Erythematosus",slug:"anti-cxcl13-and-anti-tnf-monoclonal-antibodies-combinatorial-treatment-inhibits-autoimmune-disease-i",totalDownloads:2106,totalCrossrefCites:0,signatures:"Debra B. Gardner, Patricia Rafferty, Peter Bugelski and Bailin Liang",authors:[{id:"65760",title:"Dr",name:"Debbie",middleName:null,surname:"Gardner",fullName:"Debbie Gardner",slug:"debbie-gardner"},{id:"78292",title:"Dr",name:"Bailin",middleName:null,surname:"Liang",fullName:"Bailin Liang",slug:"bailin-liang"},{id:"78769",title:"Dr",name:"Patricia",middleName:null,surname:"Rafferty",fullName:"Patricia Rafferty",slug:"patricia-rafferty"}]},{id:"31369",title:"Ocular Involvement in Behçet’s Disease",slug:"ocular-involvement-in-beh-et-s-disease",totalDownloads:3820,totalCrossrefCites:0,signatures:"Yonca Aydın Akova and Sirel Gür Güngör",authors:[{id:"67957",title:"Prof.",name:"Yonca",middleName:null,surname:"Aydin Akova",fullName:"Yonca Aydin Akova",slug:"yonca-aydin-akova"},{id:"68540",title:"Dr.",name:"Sirel",middleName:null,surname:"Gur Gungor",fullName:"Sirel Gur Gungor",slug:"sirel-gur-gungor"}]},{id:"31370",title:"Biologic Agents for Inflammatory Bowel Disease (The Current, the Future and the Controversy)",slug:"biologic-agents-for-inflammatory-bowel-disease-the-current-the-future-and-the-controversy",totalDownloads:2900,totalCrossrefCites:0,signatures:"Iyad A. Issa",authors:[{id:"63629",title:"Dr.",name:"Iyad",middleName:null,surname:"Issa",fullName:"Iyad Issa",slug:"iyad-issa"}]}]},relatedBooks:[{type:"book",id:"2026",title:"Inflammatory Diseases",subtitle:"Immunopathology, Clinical and Pharmacological Bases",isOpenForSubmission:!1,hash:"55567318dc2901acbc8cdbab9c48feef",slug:"inflammatory-diseases-immunopathology-clinical-and-pharmacological-bases",bookSignature:"Mahin Khatami",coverURL:"https://cdn.intechopen.com/books/images_new/2026.jpg",editedByType:"Edited by",editors:[{id:"63956",title:"Dr.",name:"Mahin",surname:"Khatami",slug:"mahin-khatami",fullName:"Mahin Khatami"}],equalEditorOne:null,equalEditorTwo:null,equalEditorThree:null,productType:{id:"1",chapterContentType:"chapter",authoredCaption:"Edited by"},chapters:[{id:"28054",title:"Dementia – A Complete Literature Review on Various Mechanisms Involves in Pathogenesis and an Intracerebroventricular Streptozotocin Induced Alzheimer’s Disease",slug:"alzheimer-s-disease-an-updated-review-on-pathogenesis-and-intracerebroventricular-streptozotocin-ind",signatures:"Sidharth Mehan, Rimpi Arora, Vandana Sehgal, Deepak Sharma and Garuav Sharma",authors:[{id:"62989",title:"Dr.",name:"Sidharth",middleName:null,surname:"Mehan",fullName:"Sidharth Mehan",slug:"sidharth-mehan"}]},{id:"28055",title:"Cachexia – The Interplay Between the Immune System, Brain Control and Metabolism",slug:"cachexia-the-interplay-between-the-immune-system-brain-control-and-metabolism",signatures:"Andrea Stofkova",authors:[{id:"63319",title:"PhD.",name:"Andrea",middleName:null,surname:"Stofkova",fullName:"Andrea Stofkova",slug:"andrea-stofkova"}]},{id:"28056",title:"Innate Immune System in Sepsis Immunopathogenesis and Its Modulation as a Future Therapeutic Approach",slug:"innate-immune-system-in-sepsis-immunopathogenesis-and-its-modulation-as-future-therapeutic-approach",signatures:"Vijay Kumar",authors:[{id:"63844",title:"Dr.",name:"Vijay",middleName:null,surname:"Kumar",fullName:"Vijay Kumar",slug:"vijay-kumar"}]},{id:"28057",title:"Psoriasis and Diabetes",slug:"psoriasis-and-diabetes",signatures:"Ermira Vasili, Migena Vargu, Genc Burazeri, Katerina Hysa, Elna Cano and Brikena Bezati",authors:[{id:"63608",title:"Prof.",name:"Ermira",middleName:null,surname:"Vasili",fullName:"Ermira Vasili",slug:"ermira-vasili"},{id:"69234",title:"Dr.",name:"Migena",middleName:null,surname:"Vargu",fullName:"Migena Vargu",slug:"migena-vargu"},{id:"69238",title:"Dr.",name:"Katerina",middleName:null,surname:"Hysi",fullName:"Katerina Hysi",slug:"katerina-hysi"},{id:"69240",title:"Dr.",name:"Genc",middleName:null,surname:"Burazeri",fullName:"Genc Burazeri",slug:"genc-burazeri"},{id:"122604",title:"Dr.",name:"Brikena",middleName:null,surname:"Bezati",fullName:"Brikena Bezati",slug:"brikena-bezati"},{id:"122605",title:"Dr.",name:"Elna",middleName:null,surname:"Cano",fullName:"Elna Cano",slug:"elna-cano"}]},{id:"28058",title:"Inflammation and Pulmonary Fibrosis",slug:"the-role-of-inflammation-in-pulmonary-fibrosis",signatures:"Michael G. Crooks, Imran Aslam and Simon P. Hart",authors:[{id:"63764",title:"Dr.",name:"Simon",middleName:"Paul",surname:"Hart",fullName:"Simon Hart",slug:"simon-hart"},{id:"63766",title:"Dr.",name:"Michael",middleName:"George",surname:"Crooks",fullName:"Michael Crooks",slug:"michael-crooks"},{id:"63767",title:"Dr.",name:"Imran",middleName:null,surname:"Aslam",fullName:"Imran Aslam",slug:"imran-aslam"}]},{id:"28059",title:"Inflammation in Age-Related Macular Degeneration – Implications for Therapy",slug:"inflammation-in-age-related-macular-degeneration-implications-for-therapy",signatures:"Mei Chen and Heping Xu",authors:[{id:"64019",title:"Dr.",name:"Heping",middleName:null,surname:"Xu",fullName:"Heping Xu",slug:"heping-xu"},{id:"64045",title:"Dr.",name:"Mei",middleName:null,surname:"Chen",fullName:"Mei Chen",slug:"mei-chen"}]},{id:"28060",title:"Inflammatory Periprosthetic Bone Loss",slug:"biology-of-inflammatory-periprosthetic-bone-loss",signatures:"Sang-Soo Lee, P. Edward Purdue and Ju-Suk Nam",authors:[{id:"63730",title:"Dr.",name:"Sang-Soo",middleName:null,surname:"Lee",fullName:"Sang-Soo Lee",slug:"sang-soo-lee"},{id:"120130",title:"Dr.",name:"Ju-Suk",middleName:null,surname:"Nam",fullName:"Ju-Suk Nam",slug:"ju-suk-nam"},{id:"120131",title:"Dr.",name:"P. Edward",middleName:null,surname:"Purdue",fullName:"P. Edward Purdue",slug:"p.-edward-purdue"}]},{id:"28061",title:"Acute Appendicitis – Propedeutics and Diagnosis",slug:"acute-appendicitis-propedeutics-and-diagnosis",signatures:"Andy Petroianu",authors:[{id:"62931",title:"Prof.",name:"Andy",middleName:null,surname:"Petroianu",fullName:"Andy Petroianu",slug:"andy-petroianu"}]},{id:"28062",title:"Neoplastic Pericardial Disease",slug:"neoplastic-pericardial-disease",signatures:"Mitja Letonja",authors:[{id:"63833",title:"Dr.",name:"Mitja",middleName:null,surname:"Letonja",fullName:"Mitja Letonja",slug:"mitja-letonja"}]},{id:"28063",title:"Tolerogenic Dendritic Cells for Therapy of Immune-Mediated Inflammatory Diseases",slug:"tolerogenic-dendritic-cells-for-therapy-of-immune-mediated-diseases",signatures:"Urban Švajger and Borut Štrukelj",authors:[{id:"63004",title:"Dr.",name:"Urban",middleName:null,surname:"Švajger",fullName:"Urban Švajger",slug:"urban-svajger"},{id:"109429",title:"Prof.",name:"Borut",middleName:null,surname:"Štrukelj",fullName:"Borut Štrukelj",slug:"borut-strukelj"}]},{id:"28064",title:"Prohepcidin and Hepcidin in Acute Phase Reaction Accompanying Large Cardiac Surgery",slug:"prohepcidin-and-hepcidin-in-acute-phase-reaction-accompanying-large-cardiac-surgery",signatures:"Pavel Maruna, Martin Vokurka and Jaroslav Lindner",authors:[{id:"47250",title:"Dr.",name:"Pavel",middleName:null,surname:"Maruna",fullName:"Pavel Maruna",slug:"pavel-maruna"},{id:"47255",title:"Dr.",name:"Jaroslav",middleName:null,surname:"Lindner",fullName:"Jaroslav Lindner",slug:"jaroslav-lindner"},{id:"47256",title:"Prof.",name:"Martin",middleName:null,surname:"Vokurka",fullName:"Martin Vokurka",slug:"martin-vokurka"}]},{id:"28065",title:"Leukotriene A4 Hydrolase – An Evolving Therapeutic Target",slug:"updates-in-leukotriene-a4-hydrolase-evolving-pharmacologic-target",signatures:"Y. Michael Shim and Mikell Paige",authors:[{id:"63856",title:"Dr.",name:"Yun",middleName:null,surname:"Shim",fullName:"Yun Shim",slug:"yun-shim"},{id:"64063",title:"Prof.",name:"Mikell",middleName:null,surname:"Paige",fullName:"Mikell Paige",slug:"mikell-paige"}]},{id:"28066",title:"Relationship Between Protein Oxidation Markers and Oxidative Stress Biomarkers",slug:"relationship-between-protein-oxidation-markers-and-oxidative-stress-biomarkers",signatures:"Silvia Clara Kivatinitz",authors:[{id:"63625",title:"Prof.",name:"Silvia",middleName:null,surname:"Kivatinitz",fullName:"Silvia Kivatinitz",slug:"silvia-kivatinitz"}]},{id:"28067",title:"Characterization of Acute-Phase Proteins (Apps)",slug:"characterizaton-of-acute-phase-proteins-apps-",signatures:"Sin Tak Chu and Ying Chu Lee",authors:[{id:"45125",title:"Dr.",name:"Sin Tak",middleName:null,surname:"Chu",fullName:"Sin Tak Chu",slug:"sin-tak-chu"},{id:"118004",title:"MSc.",name:"Ying-Chu",middleName:null,surname:"Lee",fullName:"Ying-Chu Lee",slug:"ying-chu-lee"}]},{id:"28068",title:"Polymerized Type I Collagen Reverts Airway Hyperresponsiveness and Fibrosis in a Guinea Pig Asthma Model",slug:"polymerized-type-i-collagen-reverts-airway-hyperresponsiveness-and-fibrosis-in-a-guinea-pig-asthma-m",signatures:"Blanca Bazán-Perkins, Maria G. Campos and Edgar Sánchez-Guerrero",authors:[{id:"63737",title:"Dr.",name:"Blanca",middleName:null,surname:"Bazán-Perkins",fullName:"Blanca Bazán-Perkins",slug:"blanca-bazan-perkins"},{id:"69368",title:"Dr.",name:"Maria G.",middleName:null,surname:"Campos",fullName:"Maria G. Campos",slug:"maria-g.-campos"},{id:"69371",title:"BSc.",name:"Edgar",middleName:null,surname:"Sanchez-Guerrero",fullName:"Edgar Sanchez-Guerrero",slug:"edgar-sanchez-guerrero"}]},{id:"28069",title:"Genetic Variation in Resistance to Inflammation and Infectious Disease",slug:"genetic-variation-in-resistance-to-infection-and-inflammation-",signatures:"Heng-wei Cheng",authors:[{id:"68434",title:"Dr.",name:null,middleName:null,surname:"Cheng",fullName:"Cheng",slug:"cheng"}]},{id:"28070",title:"Acute Phase Proteins – Analysis, Clinical Applications and Potentials",slug:"acute-phase-proteins-analysis-clinical-applications-and-potentials",signatures:"Shahabeddin Safi",authors:[{id:"34745",title:"Dr.",name:"Shahabeddin",middleName:null,surname:"Safi",fullName:"Shahabeddin Safi",slug:"shahabeddin-safi"}]},{id:"28071",title:"Supercritical Fluid Extraction of Oregano (Origanum vulgare) Essentials Oils Show some In Vitro Anti-Inflammatory Effects Based on Modifying Adipokine Secretion and Gene Expression on TNF-a-Induced Adipocytes",slug:"supercritical-fluid-extraction-of-oregano-origanum-vulgare-essentials-oils-show-some-in-vitro-anti-i",signatures:"A. Ocaña-Fuentes",authors:[{id:"66558",title:"Dr.",name:"Aurelio",middleName:null,surname:"Ocaña-Fuentes",fullName:"Aurelio Ocaña-Fuentes",slug:"aurelio-ocana-fuentes"},{id:"126054",title:"Dr.",name:"G",middleName:null,surname:"Reglero",fullName:"G Reglero",slug:"g-reglero"}]}]}]},onlineFirst:{chapter:{type:"chapter",id:"57619",title:"Modeling Quality of Service Techniques for Packet-Switched Networks",doi:"10.5772/intechopen.71499",slug:"modeling-quality-of-service-techniques-for-packet-switched-networks",body:'\nQuality of service (or simply QoS) is the ability to provide different priorities to different applications, users or dataflows, or to guarantee a certain level of performance to a dataflow [1]. For example, a computer network can guarantee certain levels of error rate or jitter, or maximal delay of transmitted information. Quality of service guarantees are important if the network capacity is insufficient, especially for real-time streaming multimedia applications such as voice over internet (voice over IP), TV over internet (TV over IP), or multimedia applications, since these are often delay sensitive and require fixed bit rate [1, 2]. Similarly, quality of service is essential in networks where the capacity can be a limiting factor, for example, in cellular data communication [3].
\nThere are two principal approaches to QoS in modern packet-switched IP networks, an integrated services approach based on application requirements that are exchanged with the network, and a differentiated approach where each packet identifies a desired service level to the network [4]. Early networks used the integrated services approach. It was realized, however, that in broadband networks, the core routers are required to deal with tens of thousands of service requirements—the integrated services approach does not scale well with the growth of the internet. Routers supporting differentiated services configure their network schedulers to use multiple queues for packets awaiting transmission. In practice, packets requiring low jitter (e.g., voice over IP or videoconferencing) are given priority over packets of other types. Typically, some bandwidth is also allocated to network control packets, which must be sent over the network without any unnecessary delay.
\nModern packet-switched networks are complex structures [5], which, for modeling, require a flexible formalism that can easily handle concurrent activities as well as synchronization of different events and processes that occur in such networks. Petri nets [6, 7] are such formal models.
\nAs formal models, Petri nets are bipartite directed graphs, in which two types of vertices represent, in a very general sense, conditions and events. An event can occur only when all conditions associated with it (represented by arcs directed to the event) are satisfied. An occurrence of an event usually satisfies some other conditions, indicated by arcs directed from the event. So, an occurrence of one event causes some other event (or events) to occur, and so on.
\nIn order to study performance aspects of systems modeled by Petri nets, the durations of modeled activities must also be taken into account. This can be done in different ways, resulting in different types of temporal nets. In timed Petri nets [8], occurrence times are associated with events, and the events occur in real time (as opposed to instantaneous occurrences in other models). For timed nets with constant or exponentially distributed occurrence times, the state graph of a net is a Markov chain (or an embedded Markov chain), in which the stationary probabilities of states can be determined by standard methods [9]. These stationary probabilities are used for the derivation of many performance characteristics of the model [10].
\nIn this chapter, timed Petri nets are used to model priority queuing systems, which provide the quality of service in packet-switched networks. Section 2 recalls basic concepts of Petri nets and timed Petri nets. Section 3 discusses (strict) priority queuing and its performance characteristics. Fair scheduling is described and illustrated in Section 4, while Section 5 deals with weighted fair scheduling. A combined approach, using several types of scheduling methods, is outlined in Section 6. Section 7 concludes the chapter.
\nIn Petri nets, concurrent activities are represented by tokens, which can move within a (static) graphlike structure of the net. More formally, a marked inhibitor place/transition Petri net \n
A place is shared if it is connected to more than one transition. A shared place p is free choice if the sets of places connected by directed arcs and inhibitor arcs to all transitions sharing p are identical. A shared place p is (dynamically) conflict free if for each marking reachable from the initial marking at most one transition sharing p is enabled. A net is a free choice if all its shared places are either free choice or (dynamically) conflict free. Only free-choice nets are used in this chapter.
\nIn timed nets [8], occurrence times are associated with transitions, and transition occurrences are real-time events; i.e., tokens are removed from input places at the beginning of the occurrence period, and they are deposited to the output places at the end of this period. All occurrences of enabled transitions are initiated in the same instants of time in which the transitions become enabled (although some enabled transitions may not initiate their occurrences). If, during the occurrence period of a transition, the transition becomes enabled again, a new, independent occurrence can be initiated, which will overlap with the other occurrence(s). There is no limit on the number of simultaneous occurrences of the same transition (sometimes, this is called infinite occurrence semantics). Similarly, if a transition is enabled “several times” (i.e., it remains enabled after initiating an occurrence), it may start several independent occurrences in the same time instant.
\nMore formally, a free-choice timed Petri net is a triple, \n
The occurrence times of transitions can be either deterministic or stochastic (i.e., described by some probability distribution function); in the first case, the corresponding timed nets are referred to as D-timed nets [11]; in the second, for the (negative) exponential distribution of occurrence times, the nets are called M-timed nets (Markovian nets) [12]. In both cases, the concepts of state and state transitions have been formally defined and used in the derivation of different performance characteristics of the model. In simulation applications, other distributions can also be used; for example, the uniform distribution (U-timed nets) is sometimes a convenient option. In timed Petri nets, different distributions can be associated with different transitions in the same model providing flexibility that is used in simulation examples that follow.
\nIn timed nets, the occurrence times of some transitions may be equal to zero, which means that the occurrences are instantaneous; all such transitions are called immediate (while the others are called timed). Since the immediate transitions have no tangible effects on the (timed) behavior of the model, it is convenient to “split” the set of transitions into two parts, the set of immediate and the set of timed transitions, and to first perform all occurrences of the (enabled) immediate transitions, and then (still in the same time instant), when no more immediate transitions are enabled, to start the occurrences of (enabled) timed transitions. It should be noted that such a convention effectively introduces the priority of immediate transitions over the timed ones, and therefore conflicts of timed and immediate transitions are not allowed in timed nets. Detailed characterization of the behavior or timed nets with immediate and timed transitions is given in [8].
\nThe basic idea of priority scheduling [13] is that separate queues are used by servers for packets of different priority classes, as shown in Figure 1 (there are three classes of priorities with queues Q1, Q2, and Q3, for example, for voice, video and data packets, respectively). It is assumed that priorities decrease with the queue numbers; i.e., Q1 is the highest priority queue. In Figure 1, a1 is the arrival rate of packets in priority class 1, a2 is the arrival rate in class 2, and s is the service rate; 1/s is the average transmission time of a packet over the communication channel (represented as the server in Figure 1). For simplicity of the description, it is assumed that the transmission times are (approximately) the same for packets of different classes, but this can easily be replaced by rates s1, s2, and s3.
\nPriority queuing.
To select a packet for transmission, the scheduler first checks the highest priority queue (Q1) and if this queue is nonempty, the scheduler uses the first packet from this queue. If Q1 is empty, the scheduler checks the next queue in the order of priorities (i.e., Q2 and then Q3). Consequently, a lowest priority packet is transmitted only when all other (higher priority) queues are empty.
\nFigure 2 shows a Petri net model of priority queuing outlined in Figure 1. Transitions t01, t02, and t03 with places p01, p02, and p03 are (independent) sources of packets for classes 1, 2, and 3, respectively. The rates of generated packets are determined by the occurrence times associated with t01, t02, and t03; a1 = 1/f(t01), etc. Also, the mode of the timed transition (M, D, or U) determines the distribution of the interarrival times for the respective source.
\nTimed Petri net model of priority queuing.
Transitions t1, t2, and t3 model the transmission times for packets of classes 1, 2, and 3, respectively. Place p5, shared by these three transitions, guarantees that no two packets can be transmitted at the same time. Finally, the inhibitor arcs (p1, t2), (p1, t3), and (p2, t3) implement the priorities: if there is a packet of class 1 waiting for transmission (in p1), no packet of class 2 or 3 can be transmitted; if there is a packet of class 1 or 2, no class 3 packet can be transmitted.
\nThe priority scheme works well when the traffic intensity is small; when, however, the traffic becomes intensive, it is quite possible that bursts of packets of higher priorities can (temporarily) block the transmission of lower priority packets for extended periods of time, significantly degrading their performance. Figure 3 shows the utilization of a transmission channel shared by three streams of packets (as in Figure 1) as a function of traffic intensity of packets of priority 1, ρ1, with fixed traffic intensities for packets of priorities 2 and 3 (at the values of ρ2 = 0.5 and ρ3 = 0.25).
\nChannel utilization as a function of ρ1 with ρ2 = 0.5 and ρ3 = 0.25.
It can be observed that for traffic intensity ρ1 > 0.25, i.e., ρ1 > 1.0 − ρ2 − ρ3, channel utilization for packets of priority 3 decreases to zero; for ρ1 ≥ 0.5, packets of priority 3 are blocked. Similarly, for ρ1 > 0.5, the utilization of the channel for packets of priority 2 decreases, which means that only some of such packets can be send through the channel.
\nWaiting times of packets with priorities 1, 2, and 3, for the case shown in Figure 3, are presented in Figure 4. As the traffic intensity ρ1 approaches 0.25, waiting times for packets of priority 3 increase indefinitely, and for ρ1 approaching 0.5, so do waiting times of packets of priority 2.
\nAverage waiting times as functions of traffic intensity ρ1 with ρ2 = 0.5 and ρ3 = 0.25.
It should be noted that for ρ1 > 0.25, queue Q3 (with infinite capacity) is nonstationary as the rate of packets entering the queue is greater than the rate of packets removed from it (for transmission through the channel). Similarly, queue Q2 (with infinite capacity) is also nonstationary for ρ1 > 0.5. This is the reason that, in Figure 4, waiting times are shown only for stationary regions of behavior.
\nIn fair queuing [14], a transmission medium is shared (in a fair way, i.e., in “equal parts”) by all classes of traffic (and the classes of traffic correspond to different packet flows, e.g., voice over IP, video, etc.). Implementations of fair queuing use separate queues for different classes of traffic, and packets are forwarded from these queue in a cyclic way, providing the same service for all classes.
\nTimed Petri nets model of fair queuing with three classes of traffic (as in Figure 1) is shown in Figure 5.
\nTimed Petri net model of fair queuing.
Places p1, p2, and p3 are queues for classes 1, 2, and 3, respectively. If the queues for all classes are nonempty, the selection is performed cyclically in a loop:
This loop is modified if (at the selection time) some queues are empty. For example, if after selecting a packet of class 1 packet, the queue for class 2 is empty, while the queue for class 3 is nonempty, the sequence is:
If the only nonempty queue is the queue for class 1, the sequence is
Generally, there are three cases when packets are selected from (nonempty) queue 1:
queue 1 is checked in the order of fair queuing (marked place p31) and the queue is nonempty (i.e., transition t11 can occur),
queue 3 is checked in the order of fair queuing (marked place p23), but the queue is empty so queue 1 is checked as the next one and it is nonempty (i.e., transition t13 can occur),
queue 2 is checked in the order of fair queuing, but queue 2 as well as the next queue, queue 3, are empty, while queue 1 is nonempty (i.e., transition t12 can occur).
There are similar cases for queues 2 and 3.
\nIt should be observed, that the set of places:
always contains a single token (initially shown in p31 in Figure 5). The cyclic checking of queues of fair queuing is controlled by this token.
\nFigure 6 shows the average waiting times for a system with fair queuing and three classes of traffic when the traffic intensities are the same for all three classes. Since the service rates are also the same for all classes, channel utilizations as well the average waiting times for are the same in this case for all classes of traffic.
\nAverage waiting times as functions of traffic intensity ρ with ρ1 = ρ2 = ρ3.
If, however, traffic intensities are different for different classes, average waiting times as well as utilizations of the shared transmission channel are also different. Figure 7 shows the average waiting times for the case when ρ1 = 0.5ρ, ρ2 = ρ3 = 0.25ρ.
\nAverage waiting times as functions of traffic intensity ρ with ρ1 = 0.5ρ, ρ2 = ρ3 = 0.25ρ.
In this case, the average waiting times for traffic classes with greater traffic intensity (class 1) increase much faster with increasing traffic intensity than for other classes of traffic (classes 2 and 3).
\nWeighted fair scheduling [13] restricts the priority scheduling by introducing limits on the number of consecutive packets of the same class that can be transmitted over the channel; when the scheduler reaches such a limit, it switches to the next nonempty priority queue and follows the same rule. So, if there are sufficient supplies of packets in all priority classes, the scheduler selects w1 packets of class 1, then w2 packets of class 2, then w3 packets of class 3, and again w1 packets of class 1, and so on, where w1, w2, and w3 are the weights for classes 1, 2 and 3, respectively. Consequently, in such a situation (i.e., for sufficient supply of packets in all classes), the channel is shared by the packets of all priority classes, and the proportions are
where k is the number of priority classes and si, i = 1, …, k, is the transmission rate for packets of class i. If the transmission rates are the same for packets of all priority classes (as is assumed for simplicity in the illustrating examples), the properties are
For an example with three priority classes and the weights equal to 4, 2, and 1 for classes 1, 2, and 3, respectively, these “utilizations bounds” are equal to 4/7, 2/7, and 1/7, for classes 1, 2, and 3, respectively.
\nA Petri net model of weighted fair scheduling for three priority classes with weights 4, 2, and 1 is shown in Figure 8. The model is composed of three identical interconnected sections corresponding to the three priority classes. The main elements of the model are the three queues represented by places p1, p2, and p3 for classes 1, 2 and 3, respectively, and timed transitions t1, t2, and t3 modeling the transmission of selected packets through the communication channel. The three classes of packets are generated (independently) by transitions t01, t02, and t03 with places p01, p02, and p03.
\nPetri net model of weighted fair queuing with weights 4-2-1.
As in fair queuing, the scheduling is based on cyclic selection of queues for the transmission of waiting packets. This cyclic operation is represented by a (rather complex) loop with places r1, r2, and r3; q1, q2, and q3; and also s1, s2, and s3. There is a single “control token” in this loop (shown in place s3 in Figure 8). This token always indicates the queue that is used for transmission of packets.
\nThe section for class 2 is shown separately in Figure 9 to make its description easier to follow.
\nPetri net model of class 2 of weighted fair queuing.
Place r2 becomes marked only when nonempty queue 2 is used for the selection of packets. Place w2 contains the weight of class 2 (in this case 2). Transition a2 selects a packet (from p2) and forwards it to p20, moving a single token from w2 to u2. When the channel becomes available (i.e., p5 becomes marked), the selected packet is forwarded from p20 to p22 and then is transmitted (transition t2). At the same time, a token is returned by t20 to r2 to allow selecting another packet from p2. This is repeated until:
there are no more token in w2 (transition c2 occurs), or
there are no more token in p2 (transition d2 occurs).
In both cases, the token from r2 is moved to q2 and then a number of occurrences of b2 moves all tokens form u2 back to w2. When u2 becomes unmarked, transition e2 moves the token from q2 to s2 in order to select the next traffic class. If p3 is nonempty, transition t23 moves the token from s2 to r3. If p3 is unmarked and p1 is marked, transition t21 moves the token from s2 to r1. If both p1 and p3 are unmarked but p2 is marked, transition t22 moves the token from s2 to r2 and transmission of class 2 packets continues. Finally, if none of t21, t22, and t23 is enabled, the token remains in s2 waiting for a packet arriving to p1, p2, or p3.
\nIt should be observed that when the traffic is intense, i.e., when the queues p1, p2, and p3 are nonempty most of the time, the queuing mechanism repeatedly selects w1 packets from p1, then w2 packets from p2, then w3 packets from p3, and so on. On the other hand, when the traffic is light, all packets are transmitted with very little delay.
\nFigure 10 shows the utilization of the transmission channel shared by three classes of packets (as in Figure 1) as a function of traffic intensity of traffic class 1, ρ1, with fixed traffic intensities for traffic classes 2 and 3 (at the values of ρ2 = 0.5 and ρ3 = 0.25).
\nChannel utilization as a function of ρ1 with ρ2 = 0.5 and ρ3 = 0.25.
For ρ1 > 0.25, channel utilization for packets of priority 3 decreases from the initial value of 0.25 to its weighted value of 0.14 (i.e., 1/7). Also, channel utilization for packets of priority 2 decreases from its initial value of 0.5 to its weighted value of 0.28 (i.e., 2/7). At ρ1 = 0.57 (i.e., 4/7), the total utilization of the channel becomes 100% and no further increase of utilization is possible.
\nSimilarly as before (Figures 3 and 4), queues Q2 and Q3 are nonstationary for ρ1 > 0.25 and queue Q1 is nonstationary for ρ1 > 0.57 (i.e., 4/7).
\nFor the same weights but for different (fixed) arrival rates for classes 2 and 3, i.e., for ρ2 = 0.25 and ρ3 = 0.1, the utilization of the transmission channel as a function of traffic intensity of traffic class 1 is shown in Figure 11.
\nChannel utilization as a function of ρ1 with ρ2 = 0.25 and ρ3 = 0.1.
For this case, queues Q2 and Q3 are stationary for 0 ≤ ρ1 < 1 and Q3 is nonstationary for ρ1 > 0.65 (i.e., 1.0–0.25–0.1). The average waiting times for classes 2 and 3 depend in a limited way on the traffic intensity ρ1, as shown in Figure 12.
\nAverage waiting times as functions of ρ1 with ρ2 = 0.25 and ρ3 = 0.1.
In weighted fair queuing, if weights are equal to the arrival rates, the traffic of lower priority classes is (almost) independent of the traffic intensity of higher-priority classes; the effect is similar to assigning some (shared) transmission capacity to lower priority traffic classes. Moreover, if this “reserved” capacity is not used, it is available to other classes of traffic.
\nThe basic queuing methods discussed earlier can be combined into more complex systems. For example, the combination of priority queuing and weighted fair queuing is known as low-latency queuing (LLQ) [15]. A simpler case of combining priority queuing and fair queuing, as shown in Figure 13, is used as an illustration of the combined approach.
\nPriority queuing combined with fair queuing.
It is assumed in this example that 40% of bandwidth is allocated to the priority queue (Q1) and that the remaining 60% of bandwidth is equally divided among queues Q2, Q3 and Q4.
\nAverage waiting times for all four classes of traffic (Figure 13) as functions of traffic intensity are shown in Figure 14.
\nAverage waiting times as functions of ρ with ρ1 = 0.4ρ and ρ2 = ρ3 = ρ4 = 0.2ρ.
Figure 14 shows the effects of priority scheduling (class 1) on lower priority classes (classes 2, 3, and 4) when traffic intensity approaches 1—the average waiting times increase rather significantly for classes 2, 3, and 4 while class 1 remains practically unaffected by the increased traffic. Also, because of fair queuing, the average waiting times for classes 2, 3, and 4 are practically identical.
\nThe Internet 2 project, launched in 2001, was probably too early for implementation of QoS protocols with the equipment that was then available [16]. It should not be surprising that this resulted in a conclusion that adding more bandwidth (i.e., over-provisioning) is more effective than any of the various schemes for accomplishing QoS [17]. But cost and other factors prevent service providers to built and maintain permanently over-provisioned networks; other approaches must be used to guarantee the performance of services available in modern packet-switched networks [16].
\nSeveral models of techniques used for providing quality of service in packet-switched networks are discussed in this chapter. These models are used to derive performance characteristics of scheduling methods and to provide some insights into the behavior of packet-switched networks. In particular, the blocking of lower priority classes of traffic, typical for priority scheduling, can easily be observed. Also, the guaranteed levels of service of fair scheduling and weighted fair scheduling can easily be illustrated.
\nIt should be noted, however, that the discussed techniques are just basic elements of complex computer networks and that the behavior of real systems is very dynamic and usually difficult to predict [18]. Therefore, more work is needed in this area to use the networks in an efficient and predictable way.
\nAlso, an attractive aspect of the models would be some kind of compositionality that would allow models to be easily combined into more complex ones, as outlined in Section 6. The models presented in this chapter need to be revised to make such compositions straightforward.
\nThe Open Access model is applied to all of our publications and is designed to eliminate subscriptions and pay-per-view fees. This approach ensures free, immediate access to full text versions of your research.
",metaTitle:"Open Access Publishing Fees",metaDescription:"Open Access Publishing Fees",metaKeywords:null,canonicalURL:"/page/OA-publishing-fees",contentRaw:'[{"type":"htmlEditorComponent","content":"As a gold Open Access publisher, an Open Access Publishing Fee is payable on acceptance following peer review of the manuscript. In return, we provide high quality publishing services and exclusive benefits for all contributors. IntechOpen is the trusted publishing partner of over 118,000 international scientists and researchers.
\\n\\nThe Open Access Publishing Fee (OAPF) is payable only after your full chapter, monograph or Compacts monograph is accepted for publication.
\\n\\nOAPF Publishing Options
\\n\\n*These prices do not include Value-Added Tax (VAT). Residents of European Union countries need to add VAT based on the specific rate in their country of residence. Institutions and companies registered as VAT taxable entities in their own EU member state will not pay VAT as long as provision of the VAT registration number is made during the application process. This is made possible by the EU reverse charge method.
\\n\\nServices included are:
\\n\\nSee our full list of services here.
\\n\\nWhat isn't covered by the Open Access Publishing Fee?
\\n\\nIf your manuscript:
\\n\\nYour Author Service Manager will inform you of any items not covered by the OAPF and provide exact information regarding those additional costs before proceeding.
\\n\\nOpen Access Funding
\\n\\nTo explore funding opportunities and learn more about how you can finance your IntechOpen publication, go to our Open Access Funding page. IntechOpen offers expert assistance to all of its Authors. We can support you in approaching funding bodies and institutions in relation to publishing fees by providing information about compliance with the Open Access policies of your funder or institution. We can also assist with communicating the benefits of Open Access in order to support and strengthen your funding request and provide personal guidance through your application process. You can contact us at oapf@intechopen.com for further details or assistance.
\\n\\nFor Authors who are still unable to obtain funding from their institutions or research funding bodies for individual projects, IntechOpen does offer the possibility of applying for a Waiver to offset some or all processing feed. Details regarding our Waiver Policy can be found here.
\\n\\nAdded Value of Publishing with IntechOpen
\\n\\nChoosing to publish with IntechOpen ensures the following benefits:
\\n\\nBenefits of Publishing with IntechOpen
\\n\\nAs a gold Open Access publisher, an Open Access Publishing Fee is payable on acceptance following peer review of the manuscript. In return, we provide high quality publishing services and exclusive benefits for all contributors. IntechOpen is the trusted publishing partner of over 118,000 international scientists and researchers.
\n\nThe Open Access Publishing Fee (OAPF) is payable only after your full chapter, monograph or Compacts monograph is accepted for publication.
\n\nOAPF Publishing Options
\n\n*These prices do not include Value-Added Tax (VAT). Residents of European Union countries need to add VAT based on the specific rate in their country of residence. Institutions and companies registered as VAT taxable entities in their own EU member state will not pay VAT as long as provision of the VAT registration number is made during the application process. This is made possible by the EU reverse charge method.
\n\nServices included are:
\n\nSee our full list of services here.
\n\nWhat isn't covered by the Open Access Publishing Fee?
\n\nIf your manuscript:
\n\nYour Author Service Manager will inform you of any items not covered by the OAPF and provide exact information regarding those additional costs before proceeding.
\n\nOpen Access Funding
\n\nTo explore funding opportunities and learn more about how you can finance your IntechOpen publication, go to our Open Access Funding page. IntechOpen offers expert assistance to all of its Authors. We can support you in approaching funding bodies and institutions in relation to publishing fees by providing information about compliance with the Open Access policies of your funder or institution. We can also assist with communicating the benefits of Open Access in order to support and strengthen your funding request and provide personal guidance through your application process. You can contact us at oapf@intechopen.com for further details or assistance.
\n\nFor Authors who are still unable to obtain funding from their institutions or research funding bodies for individual projects, IntechOpen does offer the possibility of applying for a Waiver to offset some or all processing feed. Details regarding our Waiver Policy can be found here.
\n\nAdded Value of Publishing with IntechOpen
\n\nChoosing to publish with IntechOpen ensures the following benefits:
\n\nBenefits of Publishing with IntechOpen
\n\n